San Diego, CA, United States of America

Paul E Erdman

USPTO Granted Patents = 36 

 

 

Average Co-Inventor Count = 7.3

ph-index = 8

Forward Citations = 155(Granted Patents)


Location History:

  • San Deigo, CA (US) (2018)
  • San Diego, CA (US) (2002 - 2022)

Company Filing History:


Years Active: 2002-2025

Loading Chart...
Loading Chart...
Loading Chart...
36 patents (USPTO):

Title: Paul E Erdman: Pioneering Innovator in Pharmaceutical Patents

Introduction

Paul E Erdman is a prominent inventor based in San Diego, CA, renowned for his contributions to the field of pharmaceuticals. With an impressive portfolio of 35 patents, he has played a pivotal role in developing innovative solutions for various medical challenges. His work focuses on creating compounds that address diseases associated with protein malfunction, significantly impacting cancer treatment and other disorders.

Latest Patents

Among his latest inventions are the "Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith." This patent encompasses diaminopyrimidine compounds formulated to offer therapeutic benefits. Additionally, he has developed aminoamide compounds that incorporate amino amide linkers, along with pharmaceutical compositions and medicaments containing these compounds. These innovations are designed to treat or mitigate conditions related to protein malfunction, notably including cancer.

Career Highlights

Throughout his career, Paul has made significant strides in the pharmaceutical industry by working with leading companies such as Biotheryx, Inc. and Signal Pharmaceuticals, Inc. His expertise has contributed to advancing drug development and improving therapeutic outcomes for patients facing serious health challenges.

Collaborations

Paul has also collaborated with notable professionals, including Kyle W H Chan and Leah M Fung. These partnerships have further enhanced the innovation process, bringing diverse perspectives and expertise to the projects they undertook together.

Conclusion

In conclusion, Paul E Erdman's dedication to innovation and his extensive patent portfolio underscore his impact on pharmaceutical research and development. His groundbreaking compounds and commitment to addressing complex medical conditions highlight the importance of inventors in driving advancements that can change lives for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…